Form 4: Fortrea COO Mark Morais Reports Routine Stock Transactions Following RSU Vesting
Insider Transaction Report
Fortrea Holdings Inc.'s Chief Operating Officer, Mark A. Morais, reported the settlement of Restricted Stock Units and a subsequent 'sell to cover' transaction to satisfy tax obligations.
Summary
- Mark A. Morais, Chief Operating Officer of Fortrea Holdings Inc., acquired 11,007 shares of common stock on June 2, 2025, through the settlement of Restricted Stock Units (RSUs).
- These RSUs, originally granted by Laboratory Corporation of America Holdings (Labcorp) and converted to Fortrea RSUs post-spin-off, vested on June 1, 2025.
- On June 3, 2025, Mr. Morais sold 3,130 shares of Fortrea common stock at a weighted average price of $4.17 per share to cover tax withholding obligations related to the RSU vesting.
- Following these transactions, Mr. Morais beneficially owns 46,549 shares of Fortrea common stock and 99,944 Restricted Stock Units.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The vesting of RSUs is a positive event for the executive, indicating continued equity alignment. The subsequent sale is a routine, non-discretionary transaction to cover tax obligations, which is a neutral event and not indicative of negative sentiment towards the company.
Positives
- The vesting of 11,007 Restricted Stock Units indicates the fulfillment of equity compensation, aligning management's interests with shareholders.
- The transaction is a routine settlement of equity awards, reflecting standard corporate compensation practices.
Negatives
- The sale of 3,130 shares, even for tax purposes, slightly reduces the direct common stock holdings of the Chief Operating Officer.
Risks
- No specific risks are identified in this Form 4 filing, as it primarily reports routine insider transactions.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.
Management Comments
- The sales reported represent shares of Common Stock sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs.
- These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a 'sell to cover' transaction and do not represent discretionary trades by the Reporting Person.
- The Reporting Person undertakes to provide full information regarding the number of shares and prices at which the transaction was effected upon request.
Industry Context
The reported transactions are typical for executives receiving equity compensation, where a portion of vested shares is sold to cover statutory tax withholding obligations. This 'sell to cover' mechanism is a common practice across various industries for managing equity-based compensation.
Comparison to Industry Standards
- This Form 4 reports a standard 'sell to cover' transaction, which is a common and widely accepted practice for satisfying tax obligations arising from the vesting of equity awards across publicly traded companies. There are no specific comparable companies or projects mentioned in the document to assess against industry benchmarks beyond the general nature of the transaction.
Related Party Transactions
- The Restricted Stock Units (RSUs) were originally granted by Laboratory Corporation of America Holdings (Labcorp) and converted into Fortrea RSUs pursuant to the terms of an Employee Matters Agreement in connection with the spin-off of Fortrea by Labcorp. This conversion is a result of a prior related-party agreement.
Stakeholder Impact
- Shareholders: The transaction is a routine insider filing and is unlikely to have a significant direct impact on the share price or shareholder value, as the sale was non-discretionary for tax purposes.
- Employees: The vesting of RSUs demonstrates the company's commitment to its equity compensation plans for executives.
Next Steps
- No specific future actions, events, or milestones are mentioned in this Form 4 filing beyond the reported transactions.
Key Dates
| Date | Description |
|---|---|
| 06/01/2025 | Vesting date of Restricted Stock Units (RSUs) converted from Labcorp awards. |
| 06/02/2025 | Settlement date of 11,007 Restricted Stock Units into Fortrea Common Stock. |
| 06/03/2025 | Date of sale of 3,130 shares of Common Stock to cover tax withholding obligations. |
| 06/04/2025 | Date the Form 4 filing was signed. |
Keywords
Fortrea Holdings Inc., FTRE, Mark A. Morais, Chief Operating Officer, Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Sell to Cover, Equity Compensation, Stock Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.